ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:1903003;positive regulation of protein deubiquitination;10.0;0.8653626801206646;0.8479223519212526;9.5544162803384;912.3518242519174;7.8311634786251565;0.030535594494377795;0.8157270763441555;[WDR48, TANK]
GO:0050718;positive regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;998.8167007681584;6.518977089658987;0.033429496098039586;0.7658097438582601;[NLRP12, NLRP7, NLRP3, CCL19]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[NLRP12, IL23A, SPHK1, ZFP91, CCL19, LIMS1]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[CD80, HBEGF]
GO:0045765;regulation of angiogenesis;6.0;0.7043150770688792;0.675277851124584;8.817594036275793;44.93985318205118;4.1639455212923995;0.0015040964427611868;0.5360646801923071;[MAP3K3, STARD13, SPHK1, ITGB2, CIB1, THBS1, C3, SFRP1, IL6, RRAS, SP1, TBXA2R, EPHA1, GTF2I, CCR2]
GO:0007257;activation of JUN kinase activity;14.0;1.0;0.9759193652572005;9.628524252492122;8640.54909511404;6.088194173566533;0.2891914022241413;0.7872698984233759;[ERN1, CCL19]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[IL6, IL23A, CCL5]
GO:0051091;positive regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.431813958246067;277.8307104044464;4.2636448815154875;0.00929874384583087;0.650471949850128;[MTPN, UBE2I, BUD31, SPHK1, ITGB2, CIB1, NLRC4, TMEM173, PPRC1, LRP8, STK3, IL6, COPS5, EP300, TRIM14, NLRP3, TRIM32, ARHGEF5]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[C3, MAP3K3, RRAS, SP1, TBXA2R, SPHK1, ITGB2, CIB1, EPHA1, THBS1]
GO:0006957;complement activation, alternative pathway;8.0;1.0;0.875;9.628524252492122;200.06168254027287;7.212124270218933;0.006695884470798082;0.7438283705770736;[C3, CFH]
GO:0032966;negative regulation of collagen biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;106.39829570052878;7.697632086000634;0.00356105520484733;0.7167775754447168;[ERRFI1, CIITA, IL6]
GO:0030307;positive regulation of cell growth;6.0;0.6954798709641801;0.6708602480722345;8.712233520617966;80.64681300048527;4.733648510761223;0.0026991762537066665;0.5651993175676412;[MTPN, SFRP1, CSNK2A1, SPHK1, RUFY3, H3F3A, DERL2, CIB1, ADNP, TRIM32, PAFAH1B1, HBEGF]
GO:0048247;lymphocyte chemotaxis;7.0;0.7671156992804218;0.7344772148974115;9.303101852057495;94.37808318069546;5.926926025970411;0.003158749509297446;0.6540226378555745;[HSD3B7, CCL20, CCL5, CCL19, CCR2]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[NCF1, MAML1, GFI1, CD80, ARID4A, RORA, IKZF2, ELK1, YY1, ZXDC, DPF2, TRIM24, EP300, SOX8, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, ILF3, SFRP1, KARS, IL23A, RFX4, HOXB4, MAX, RLF, SUPT6H, HLTF, DVL3, SCAP, NLRP3, TFAP2A, DR1, CREBBP, PBX3, EIF2AK3, ERLIN2, FLI1, SETX, CDK9, NFKBIA, IL6, TFCP2, COPS5, SP1, SP3, MAFF, BCL3, NFE2L3, CDKN1C, CIITA, ONECUT2, ELL, DDX41, HOXC13, AATF, FLCN, NIPBL, LBH, NUP62, ZNF485, TBP, KLF13, PEG3, DTX3L, NCOA6, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, CREB3, GAL, TFDP2, MTF2, TFEC, HDAC3, ZNF350, HDAC1, WBP2, ARNTL, SERTAD3, RXRA, TP53INP2, TP53INP1, GPBP1L1, E2F7, E2F8, TBX1, ZNF462, NFYC, ATAD2, GRHL1, USF2, CD4, NFIB, NFIC, CAMK4, TAF7, CAMK1]
GO:0006958;complement activation, classical pathway;8.0;1.0;0.875;9.628524252492122;171.02669507306572;4.7081694254602375;0.005724109570062889;0.6157760033703056;[C3, C1QBP, C1QC, C2]
GO:0032722;positive regulation of chemokine production;6.0;0.7140352122741334;0.6801379187272112;8.734706376470026;66.68357405504983;5.8067817141283475;0.002231839212302133;0.6200793994936333;[IL6, IL4R, MBP, TRIM32]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[RAB3B, NCKAP1, OXTR, DGKA, CD80, SIRPG, IL5RA, DEFB1, RAB43, DOCK11, RPS6KA2, ARHGDIB, EP300, IFNAR2, IGFBP5, ERN1, BCR, DEPDC1B, KARS, ELMO1, KPNB1, DIABLO, CLEC16A, ITPR2, KRCC1, CRHR1, RASGRP4, STK3, ABR, NUAK1, RHOT1, ZMAT1, RRAS, TBXA2R, STK38, DVL3, STK38L, MBP, ECT2, MARK2, EIF2AK3, IFT122, CNOT10, RAB27B, SETX, NFKBIA, CNOT6, IRAK1BP1, COL1A2, PTPRA, CNOT1, GNAQ, RCAN3, BCL3, NMUR1, CNOT8, CALM1, CALM2, BTG2, CDKN1A, MCTP1, PRKCSH, MAST3, DOCK8, BBC3, POLB, FLCN, AKAP11, NKIRAS1, C1QBP, CASP2, RAB8B, CCR2, KSR1, SPHK1, TMEM173, GFRA2, SPTB, SIRT2, GAL, ALS2, TFDP2, TAX1BP3, LCP1, DOCK2, ARHGEF5, EXOC1, HBEGF, TANK, RAB21, GNG2, RAB20, PABPN1, CCL5, TIFA, MKNK2, NCAM1, ZNF622, BID, E2F7, E2F8, MAP3K3, CCL20, TSHR, SNRK, ITCH, CAMK4, RAB18, CCM2, CAMK1]
GO:0050830;defense response to Gram-positive bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.334422371190153;0.0023911797157970473;0.6237219733958743;[IL6, SEH1L, HIST1H2BJ, NLRP3, DEFB1, RNASE3, HIST1H2BC]
GO:0030148;sphingolipid biosynthetic process;7.0;0.6913464685778243;0.6965925995461126;8.992535485772125;238.8284648682076;5.288437257948329;0.007993373787475071;0.6213702925661609;[UGT8, SGPL1, ELOVL5, SPHK2, SPHK1, SGPP2]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IL6, CAMK1, GFRA2]
GO:1901990;regulation of mitotic cell cycle phase transition;7.0;0.6144040707577935;0.6581214006360973;8.152617732682543;36.34719157774778;3.91914047319701;0.0012165077917585339;0.551344391315166;[ANKRD17, BTG2, CDKN1A, ANAPC11, CDC26, UBD, TPR, CEP70, CASP2, EP300, BID, CLASP1, E2F7, E2F8, DACT1, FANCI, CNOT10, SENP2, CKAP5, NDC80, SIRT2, DDB1, CNOT6, CENPF, RAD51C, ESPL1, TFDP2, CNOT1, CTDSP2, PKIA, PSME2, ANAPC5, CNOT8, PAFAH1B1, EZH2, MAD2L1]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[COLEC12, VASP, PDCD6IP, KCND1, FCER1G, ATPIF1, EIF2AK3, PKD2L1, NLRC4, CLYBL, GLS, MARCKS, SPAST, RXRA, ALDH5A1, RNF213, KCTD10, IMPDH2, KCTD14, ECT2, ALDOA, BID]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[USP36, FEN1, BTG2, CDKN1A, WDR48, DCLRE1C, CIB1, AATF, YY1, POLB, NIPBL, CHAF1A, CASP2, EP300, UPF1, AQR, TIPIN, FBXO18, DTX3L, NCOA6, RAD23A, DDB1, NEIL3, RAD51C, TFDP2, MSH3, TIMELESS, TANK, RAD51AP1, NUAK1, POLR2B, POLR2G, USP51, BID, E2F7, E2F8, FANCI, UBE2B, EYA2, INTS3, GINS4, CNOT10, GTF2H4, SETX, CDK9, SMUG1, CNOT6, HIST3H2A, COPS5, CNOT1, UBE2T, BCL3, MNDA, CNOT8]
GO:0045779;negative regulation of bone resorption;7.0;1.0;0.8509193652572005;9.628524252492122;83.00611842489866;7.292166977892469;0.002778140083024753;0.7238411236270654;[IL6]
GO:0010828;positive regulation of glucose transmembrane transport;7.0;0.8933024483968273;0.7975705894556142;9.533214072687796;65.58818238534796;5.845247994956144;0.0021951774389057117;0.6498456195510879;[C3]
GO:0098586;cellular response to virus;6.0;0.7763722522362496;0.7113064387082693;8.999915593069748;28.654098265158677;6.375876246018314;9.59026881920657E-4;0.6491829203200885;[CCL19, TMEM173]
GO:0001798;positive regulation of type IIa hypersensitivity;12.0;0.9326813400603323;0.9144609826203107;9.606051396640064;1378.0251110012991;9.083926447120524;0.04612126032313042;0.9126727335416687;[C3, FCER1G]
GO:0006607;NLS-bearing protein import into nucleus;10.0;1.0;0.9152410118609203;9.628524252492122;278.22868408041535;6.481236761676141;0.009312063666612497;0.7466917612613706;[TNPO2, RGPD1, KPNB1, IPO4]
GO:0002408;myeloid dendritic cell chemotaxis;8.0;0.9326813400603323;0.8413406700301662;9.56398573135455;125.05555036753341;8.67846133901236;0.004185496728112903;0.8188169164668168;[CCL19, ARHGEF5]
GO:0072610;interleukin-12 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;9.083926447120524;0.004587596526932657;0.8797934328124444;[CCL19]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[IGFBP5, C1QBP, CD80, CCL19, THBS1, STK3, HBEGF]
GO:0035666;TRIF-dependent toll-like receptor signaling pathway;13.0;0.9326813400603323;0.9288956347978027;9.592156608321247;413.3481394832653;6.599019797332524;0.013834390239330937;0.8000291440890255;[TANK]
GO:0034695;response to prostaglandin E;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;134.30653146733928;6.599019797332524;0.004495118740180942;0.6883935445785896;[SFRP1, GNG2, CCL19]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[CDKN1C, BECN1, BTG2, CDKN1A, CD80, LST1, SIRPG, CIB1, COMT, THBS1, STK3, FLCN, ADORA3, RPS6KA2, FNTB, NUP62, TP53INP1, LMNA, TRIM24, RBM5, E2F7, TFAP2A, KLF13, IGFBP5, ATPIF1, IDH2, GLMN, IFT122, EMP3, PDCD1LG2, SIRT2, PER2, ITCH, SFRP1, TWSG1, IL6, GAL, KARS, FAP, NFIB, CD9, TAX1BP3, MNDA, CNOT8, TRIM32]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[ANKRD17, MAP3K3, CD4, UBE2I, UBD, NUP62, ZDHHC13, CCL19, ECT2, TRIM32]
GO:0008203;cholesterol metabolic process;6.0;0.7980440201809971;0.722142322680643;9.223059144383958;82.64786032185484;5.058574756385375;0.0027661495067272364;0.581816060879476;[HSD3B7, RXRA, SNX17, SCAP, ERLIN2, APOL1, SCARF1]
GO:0043124;negative regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.487551390376;6.063501560976162;0.008015432820232688;0.6850877518099798;[NLRP12, OTUD7B, RORA, TANK]
GO:0042157;lipoprotein metabolic process;5.0;0.7586651285174919;0.6695735761196662;8.999915593069748;47.85814540089318;6.221725566191056;0.001601769057033345;0.6084203466557585;[APOL1]
GO:0045669;positive regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;169.86351353303945;5.734022359845919;0.005685178930713632;0.6163584827319739;[IL6, RUNX2]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CIITA, ONECUT2, ELL, MAML1, GFI1, ARID4A, RORA, DDX41, HOXC13, AATF, IKZF2, ELK1, YY1, FLCN, NIPBL, DPF2, EP300, SOX8, IER5, ZNF564, IER2, ZNF485, KLF13, PEG3, NCOA6, ARNT, FLT3LG, SENP2, SAFB, TMEM173, PPRC1, MED6, RUNX2, SIRT2, CREB3, GAL, TFDP2, IL23A, RFX4, MTF2, TFEC, HOXB4, HDAC3, ZNF350, HDAC1, WBP2, MAX, RLF, SUPT6H, ARNTL, RXRA, HLTF, SCAP, NLRP3, E2F7, E2F8, TBX1, TFAP2A, ZNF462, DR1, CREBBP, NFYC, ATAD2, PBX3, ERLIN2, GRHL1, USF2, FLI1, SETX, CDK9, NFKBIA, IL6, TFCP2, COPS5, SP1, NFIB, NFIC, SP3, MAFF, BCL3, TAF7, CAMK1]
GO:0045425;positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;833.6113263844036;9.083926447120524;0.027900220892599446;0.839552420951524;[CD80]
GO:0045668;negative regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;170.3268387162597;6.015873511986907;0.0057006860076304205;0.6307723637598831;[SFRP1, TWSG1, IGFBP5]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[ERN1, IL6, IGFBP5, ITGA2, CCL5, SKP2, THBS1, HBEGF]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[MAP3K3, OXTR, KSR1, IL5RA, GFRA2, SPTB, RASGRP4, SETX, KARS, PABPN1, PTPRA, CCL5, NCAM1, CCM2, MBP, CALM1, HBEGF]
GO:0051024;positive regulation of immunoglobulin secretion;9.0;1.0;0.896240625180289;9.628524252492122;579.4559284816147;7.379178354882098;0.019393868449801132;0.7736121494158466;[IL6]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[CIITA, CDKN1A, CD80, ITGB2, IL5RA, CIB1, RORA, LRP8, IL22RA2, CCL5, IL21R, NCAM1, CCL19, HLA-DQA1, CCR2, HLA-DPA1, IFNAR2, BBS2, MAP3K3, IL4R, CCL20, FLT3LG, YWHAZ, NFKBIA, CD4, IL6, COL1A2, KARS, IL23A, HLA-DPB1, SDC1, PSME2, LCP1, HLA-DRB3, LIMS1]
GO:0043011;myeloid dendritic cell differentiation;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;91.1712242271392;6.8867018697843045;0.003051418826107602;0.6753065664753021;[CAMK4, UBD]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[ERRFI1, CDKN1A, IL6, ABCC2, ABCA3, CAD, SDC1, UBE2L3]
GO:0070102;interleukin-6-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.138016298065211;0.00101047745553359;0.7159578506919597;[IL6]
GO:0051549;positive regulation of keratinocyte migration;9.0;1.0;0.896240625180289;9.628524252492122;297.9389118084288;7.697632086000634;0.009971747250615804;0.7898978880348613;[HBEGF]
GO:0048260;positive regulation of receptor-mediated endocytosis;8.0;0.811012628672052;0.780506314336026;9.34084218004034;175.1727623766804;5.8650506222523235;0.005862874711496551;0.6749389615747303;[RAB21, SYNJ1, CCL19]
GO:0038128;ERBB2 signaling pathway;9.0;0.8653626801206646;0.8289219652406215;9.36615998802463;32.38857880465376;6.343086423195323;0.0010840165847632744;0.7206263598461826;[HBEGF]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[CD4, IL6, NCF1, IL23A, ITGB3, CCL5, CD80, ADNP, LRP8, HBEGF]
GO:0051545;negative regulation of elastin biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;967.9208223894049;9.777073627680469;0.032395438853188026;0.896240625180289;[HBEGF]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[BECN1, USP36, WDR48, USP32, USP12, OTUD7B, NEDD8, USP39, PSMB10, PSMA7, YY1, PSMD8, POLB, VCPIP1, RHOT1, PSMD2, PSMB1, NLRP3, USP51, SKP2, USP46, RAD23A, NFKBIA, COPS5, PSMA1, PSME2, USP41]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD80, PDCD1, PDCD1LG2, CCL19]
GO:0006670;sphingosine metabolic process;8.0;0.8933024483968273;0.8216512241984136;9.52844079393514;113.73596156966032;7.292166977892469;0.003806640278016614;0.747921758369865;[SPHK2, SPHK1, SGPP2]
GO:0000209;protein polyubiquitination;10.0;0.7671156992804218;0.7987988615011312;9.223059144383958;155.4032479663248;4.243684138952949;0.005201206855589802;0.6322632160784685;[UBE2B, DTX3L, CCNF, SYVN1, ZFP91, FBXL15, LNPEP, FBXL16, ANAPC11, UBE2L3, NPEPPS, ITCH, RNF213, UBE2T, CDC26, TRIM69, FBXL3, ANAPC5, RFFL, SKP2, C18orf25, TRIM32]
GO:0043410;positive regulation of MAPK cascade;10.0;0.6634067003016617;0.7469443620117512;9.174268980214526;1017.2390743488962;3.4929394666096676;0.03404607636272706;0.5938700986216354;[TBX1, MAP3K3, FGA, KSR1, PDE6H, NCF1, CCL20, FGG, CIB1, THBS1, STK3, ERN1, CD4, IL6, KARS, CCL5, DVL3, ZNF622, CCL19, EPHA1, ARHGEF5, EZH2]
GO:0007249;I-kappaB kinase/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[NFKBIA, IRAK1BP1, NKIRAS1, TIFA, BCL3, TANK]
GO:0001781;neutrophil apoptotic process;6.0;1.0;0.8231203125901445;9.628524252492122;45.60457565231589;9.083926447120524;0.0015263441056295624;0.7876727335416686;[IL6]
GO:0030514;negative regulation of BMP signaling pathway;12.0;0.8259837884571596;0.8611122068187244;9.4949928598676;599.3292772798114;5.905872616772578;0.02005901154922404;0.7501469128630576;[SFRP1, TWSG1]
GO:0007517;muscle organ development;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;27.682183388997124;5.085725745451326;9.264977656821302E-4;0.5100842511328143;[TBX1, CENPF, VAMP5, HBEGF]
GO:0030513;positive regulation of BMP signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.571365838652174;514.640204837359;6.311337724880743;0.017224544509792043;0.770882417347765;[TWSG1, FBXL15]
GO:2000427;positive regulation of apoptotic cell clearance;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;227.08343208129315;7.8311634786251565;0.007600278109940302;0.7967266896635242;[C3, C2]
GO:2000669;negative regulation of dendritic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;128.74299079791163;7.8311634786251565;0.004308912040836728;0.7967266896635242;[CCL19]
GO:2000549;positive regulation of dendritic cell dendrite assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;9.777073627680469;0.006704083591926775;0.896240625180289;[CCL19]
GO:0001934;positive regulation of protein phosphorylation;9.0;0.5833093054345528;0.6878952778975655;8.604019935977734;663.1129447749842;2.9039097934679514;0.02219379349871355;0.5447467070638558;[CDKN1A, NCF1, ITGB3, CD80, CIB1, FLCN, FGA, FBXO18, KSR1, SPHK1, FGG, PLAUR, ZFP91, FLT3LG, SENP2, GFRA2, ERN1, TWSG1, KARS, ALS2, IL23A, JTB, ADNP, EPHA1, ARHGEF5, HBEGF, HDAC3, LRP8, THBS1, STK3, C3, CCL5, DVL3, NCKAP1L, ZNF622, CCL19, ECT2, MARK2, TBX1, MAP3K3, PDE6H, CCL20, CDK9, CD4, IL6, CDK2AP1, CAMK1, CALM1, CALM2, EZH2]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[FCER1G, CCL20, CCL5, ITGB2, NCKAP1L, CCL19]
GO:0010888;negative regulation of lipid storage;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;46.28121162512291;6.8867018697843045;0.001548990502706573;0.6753065664753021;[NFKBIA, IL6, ITGB3]
GO:0001818;negative regulation of cytokine production;5.0;0.5133656128089943;0.5469238182654175;7.031139619277432;44.35819177106142;4.304802954008995;0.0014846287587966433;0.5103888351227501;[ERRFI1, CUEDC2, OTUD7B, PDCD1LG2, THBS1, YY1, ITCH, NLRP12, TWSG1, IL6, NLRP7, IL23A, C1QBP, BCL3, NLRP3, NCKAP1L]
GO:2000660;negative regulation of interleukin-1-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;306.2706419112467;8.16763571524637;0.010250602759086841;0.7926932703116032;[IL6]
GO:0010884;positive regulation of lipid storage;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;46.19953359410991;6.686031174322154;0.0015462568125140237;0.665044257777226;[C3, OSBPL11]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[CLK1, BCR, ZMYM2, FES, TRIM24, IL5RA, ERLIN2, EPHA1, CLK4, CLK3, HBEGF]
GO:0045727;positive regulation of translation;8.0;0.6634067003016617;0.7067033501508309;9.123968241739727;1032.6861465930526;5.104244793218563;0.03456307596927652;0.6360313160968547;[RPS9, IL6, RXRA, ITGA2, C1QBP, CCL5, BCL3, POLR2G, THBS1]
GO:0032494;response to peptidoglycan;5.0;0.8653626801206646;0.7229223519212526;9.461470167828956;77.33766349313319;7.379178354882098;0.002588421997736798;0.6676125360964777;[IL6, NLRP3]
GO:1902476;chloride transmembrane transport;8.0;1.0;0.875;9.628524252492122;110.5175749436453;5.311165509025885;0.0036989237740038075;0.6466132511260384;[CLIC5, CLCN3, APOL1, BEST3]
GO:0007173;epidermal growth factor receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.040737587590003;32.38857880465376;5.788089581116195;0.0010840165847632744;0.6922437955322635;[VIL1, CAMLG, FES, FAM83A, HBEGF]
GO:0007179;transforming growth factor beta receptor signaling pathway;8.0;0.7586651285174919;0.754332564258746;9.05316010758856;29.903672154863813;5.2552850506314295;0.0010008489954655988;0.6437555218850388;[TWSG1, COL1A2]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[ERRFI1, RABGAP1, DOCK8, RIC8A, ABR, DOCK11, ARHGAP21, RGS1, CCL5, ARHGDIB, DVL3, NCKAP1L, EVI5L, CCL19, ECT2, A2M, TBC1D22A, STARD13, CCL20, TBC1D8, ARHGAP25, BCR, DEPDC1B, SFRP1, ALS2, GNAQ, PKP4, TAX1BP3, DOCK2, EPHA1, ARHGEF5, EZH2, LIMS1]
GO:0070091;glucagon secretion;9.0;1.0;0.896240625180289;9.628524252492122;103.34370176099773;9.777073627680469;0.003458820694647294;0.896240625180289;[IL6]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[HSD3B7, IL6, FCER1G, CCL20, CCL5, ITGB2, NCKAP1L, CCL19, LYST, ARHGEF5, CCR2, HBEGF]
GO:0002675;positive regulation of acute inflammatory response;8.0;0.7090535922965819;0.729526796148291;8.971744716103052;164.518653823802;6.518977089658987;0.005506291286306897;0.7083807915285978;[C3, IL6, FCER1G]
GO:0050871;positive regulation of B cell activation;8.0;0.7436939687323844;0.7468469843661922;9.117698628726131;160.32529438548238;4.695669262696007;0.00536594331968482;0.6151367444652258;[CDKN1A, IL6, TFRC, NCKAP1L]
GO:0030509;BMP signaling pathway;11.0;0.7090535922965819;0.7869557484779532;9.133828010656014;282.55034729266697;5.202362649177086;0.009456705845082177;0.6984780201431826;[TWSG1, RUNX2]
GO:0072540;T-helper 17 cell lineage commitment;8.0;1.0;0.875;9.628524252492122;46.25983793501841;7.9853141584524145;0.0015482751445338478;0.7833693374183408;[IL6]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[IFNAR2, BECN1, APOBEC3F, DTX3L, APOBEC3H, DDX41, TMEM173, LYST, UNC13D, ITCH, ILF3, IL6, POLR3C, IL23A, POLR3E, NLRP3, SERINC3, EXOC1]
GO:2000676;positive regulation of type B pancreatic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.82178199018807;8.390779266560578;0.00434501821119318;0.8253454670833372;[IL6]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[FCER1G, IL23A, CCL19, THBS1, CCR2]
GO:0051209;release of sequestered calcium ion into cytosol;14.0;0.7980440201809971;0.874941375347699;9.527428135620752;522.9340415463636;5.9928839937622085;0.01750213176047399;0.7823957313958061;[ITPR2, CCL19]
GO:0071731;response to nitric oxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;66.42530163189308;6.832634648514029;0.0022231950667291668;0.639662265535933;[CCL19]
GO:2000158;positive regulation of ubiquitin-specific protease activity;10.0;1.0;0.9152410118609203;9.628524252492122;498.23042437157306;9.083926447120524;0.0166753239254458;0.8797934328124444;[TANK]
GO:0010575;positive regulation of vascular endothelial growth factor production;6.0;1.0;0.8231203125901445;9.628524252492122;64.54350789155374;6.481236761676141;0.002160213123744424;0.6545710619905948;[C3, EIF2AK3, ARNT, RORA]
GO:2000553;positive regulation of T-helper 2 cell cytokine production;10.0;1.0;0.9152410118609203;9.628524252492122;874.8811381751227;7.9853141584524145;0.029281484352815565;0.8236103492792612;[IL6, NLRP3]
GO:0090303;positive regulation of wound healing;7.0;0.7043150770688792;0.7030769037916401;8.753055515138222;62.345319237194666;5.905872616772578;0.002086641727724376;0.6529459655301135;[TBXA2R, THBS1, HBEGF]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[OXTR, AHCYL1, SUCNR1, DGKA, DEFB1, IQGAP2, CRHR1, RIC8A, HEBP1, C3, ABR, GNG2, GNAT2, RGS1, TBXA2R, ADORA3, CCL5, NPPA, OR56B1, CCL19, ECT2, NTSR1, CCR2, SPHK2, CCL20, SPHK1, TSHR, SFRP1, GAL, GNAQ, GNB2, NMUR1, CALM1, DAGLB, CALM2, ARHGEF5]
GO:0090023;positive regulation of neutrophil chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;945.710466239641;6.343086423195323;0.03165207822087823;0.7568146869955557;[IL23A, C1QBP, NCKAP1L, CCL19]
GO:2000051;negative regulation of non-canonical Wnt signaling pathway;8.0;0.7671156992804218;0.7585578496402109;9.203641058526856;236.5222601423257;8.16763571524637;0.007916187190749309;0.7926932703116032;[SFRP1, RNF213]
GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;732.6859750532908;6.375876246018314;0.024522340210466318;0.7584915600596062;[CCL19]
GO:0002690;positive regulation of leukocyte chemotaxis;9.0;0.7508913569872202;0.7716863036738992;9.33127272902419;423.36221235109986;5.288437257948329;0.014169552246136892;0.6666915524892495;[CREB3, IL6, KARS, IL23A, C1QBP, CCL5, NCKAP1L, CCL19, THBS1, CCR2]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[SERPINA3, PDXK, SIGLEC9, CLEC12A, ITGB2, IQGAP2, C3, HK3, PSMD2, PSMB1, LAMP2, NCKAP1L, GUSB, SNAP29, SERPINB1, TMEM30A, FCER1G, HSPA6, PLAUR, COMMD3, RNASE3, TMEM173, LILRB3, UNC13D, SERPINB6, IMPDH2, RAB18, PTX3, MNDA, DOCK2, ALDOA, KPNB1]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[TFRC, CD80, PDCD1LG2, CD4, IL6, HLA-DMB, IL23A, CCL5, HLA-DPB1, NCKAP1L, CCL19, CCR2, HLA-DPA1]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[COLEC12, FCER1G, CD163L1, TFRC, AMBP, ITGB2, CLTA, FNBP1L, RABEPK, LRP8, SYNJ1, SNX17, CD9, APOL1, SCARF1]
GO:0002606;positive regulation of dendritic cell antigen processing and presentation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.28681003950749;7.8311634786251565;0.0018503997771236419;0.7236063770733796;[CCL19]
GO:0010866;regulation of triglyceride biosynthetic process;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;120.43142503018073;6.943860283624253;0.004030731414514328;0.7060287030842711;[C3]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[CMTM7, ERRFI1, UBE2I, NCF1, CCL20, BUD31, FLT3LG, IL6, GAL, IL23A, CCL5, NPPA, FAM3C, CCL19, CHMP6, KCNK3, HBEGF]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[IL6, FCER1G, MBP]
GO:2000562;negative regulation of CD4-positive, alpha-beta T cell proliferation;11.0;1.0;0.9324289523296623;9.628524252492122;1433.7336516231012;8.390779266560578;0.04798577504331058;0.8615337942327104;[TWSG1]
GO:0010862;positive regulation of pathway-restricted SMAD protein phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1012.5567145242198;5.905872616772578;0.033889361993245395;0.7172676121338334;[TWSG1]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[HIST1H2BO, HIST1H2BJ, RNF38, CCNF, NEDD8, DTX2, NLRC4, ANAPC11, UBE2L3, VCPIP1, TRIM9, NPEPPS, RNF213, HERC1, CDC26, UBD, HLTF, TRIM24, TRIM69, RFFL, SKP2, C18orf25, UBE2I, UBE2B, FBXO18, KLHL25, DTX3L, SYVN1, ZFP91, FBXL15, LNPEP, FBXL16, DDB1, ITCH, KCTD10, UBE2T, TSPAN17, FBXL3, ANAPC5, TRIM32, HIST1H2BC]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[VPS18, ITCH, GYPA, TFRC, ITGB3, ITGA2, CD80, NUP153, NCAM1]
GO:0045627;positive regulation of T-helper 1 cell differentiation;13.0;1.0;0.9625549647676366;9.628524252492122;2605.164725512912;7.9853141584524145;0.08719251886688177;0.8709243021859774;[CD80, CCL19]
GO:0010560;positive regulation of glycoprotein biosynthetic process;8.0;0.7508913569872202;0.7504456784936101;9.34084218004034;731.8700557117284;6.832634648514029;0.024495032124383954;0.7244212536750128;[CCL19]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[ITIH2, PRKCSH, SERPINA10, CCNF, NEDD8, MSLN, PSMB10, PSMA7, PSMD8, C3, PSMD2, UBD, PSMB1, SKP2, APOL1, FGA, KLHL25, IGFBP5, FGG, FBXL15, FBXL16, DDB1, IL6, COPS5, PSMA1, PSME2, FBXL3]
GO:0001970;positive regulation of activation of membrane attack complex;11.0;1.0;0.9324289523296623;9.628524252492122;1575.1603373516848;9.083926447120524;0.05271919893889256;0.8969813732811862;[C3]
GO:0045745;positive regulation of G-protein coupled receptor protein signaling pathway;7.0;0.6519675769143192;0.6769031537143602;8.647694999480395;189.39299583705403;6.409777797693995;0.006338813128036018;0.6787156999164222;[C3, PDE6H]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[CIITA, BTG2, GFI1, OTUD7B, IKZF2, YY1, FLCN, NIPBL, C1QBP, SAP130, WWC3, EP300, SOX8, LRRFIP1, ZNF564, DACT1, TLE4, KLF12, PEG3, SIRT2, EID1, MTF2, HOXB4, TIMELESS, LCOR, HDAC3, ZNF350, HDAC1, MAX, FOXG1, LRP8, RXRA, BAG3, TPR, HIVEP1, HESX1, SUDS3, E2F7, ZNF189, E2F8, IRX1, TFAP2A, DR1, CREBBP, UBE2I, PER2, GFI1B, CNOT1, NFIB, NFIC, PKIA, SP3, NFE2L3, TAF7, EZH2]
GO:0045079;negative regulation of chemokine biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.597752593825367;841.3347014012318;8.67846133901236;0.02815871530382644;0.8188169164668168;[IL6]
GO:0097029;mature conventional dendritic cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;70.62522642078902;8.390779266560578;0.002363762769726602;0.7522251544931926;[CCL19]
GO:0071479;cellular response to ionizing radiation;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;48.660440229648614;5.602686357784832;0.0016286211429333208;0.6096419534788213;[RAD51AP1, NIPBL, SFRP1, CDKN1A, ECT2, ELK1, TANK]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[SERPINA3, SERPINB1, CSTA, ITIH2, CSNK2A1, AMBP, SERPINA10, PLAUR, NLRC4, THBS1, SERPINB6, VIL1, C3, NLRP7, RFFL, A2M]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[SFRP1, ABCC2, CCL20, CCL5, CIB1, RORA, CCL19, THBS1, TANK]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[SETX, BECN1, IL6, ECT2, EZH2]
GO:0016311;dephosphorylation;5.0;0.6835726970475526;0.6320273603846966;8.32924126836186;24.405590426795786;4.076630054289783;8.168331479794688E-4;0.4987200624199847;[EYA2, SSU72, DUSP28, SSH3, SGPP2, PPM1G, DUSP14, PPP1CB, PTP4A1, POLB, PPP1CC, DUSP23, PPP6C, G6PC3, SYNJ1, PTPRA, CTDSP2, ACP2]
GO:0051865;protein autoubiquitination;10.0;1.0;0.9152410118609203;9.628524252492122;155.4032479663248;5.769740442447999;0.005201206855589802;0.7103058064080809;[ITCH, RNF213, UBE2B, DTX3L, UBE2T]
GO:0050829;defense response to Gram-negative bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.407625775213448;0.0023911797157970473;0.627465598881932;[CD4, IL6, HIST1H2BJ, IL23A, DEFB1, RNASE3]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[NAB1, GFI1, ARID4A, IKZF2, ELK1, UBE2L3, YY1, SAP130, ZXDC, DPF2, TRIM24, EP300, ZNF326, SOX8, ZNF688, IER5, ZNF564, IER2, GTF2I, TLE4, ZNF441, CSNK2A1, ZNF282, SND1, ERN1, EID1, ILF3, ZNF93, RFX4, HOXB4, TIMELESS, ADNP, ZNF276, ZNF550, ZNF395, ZNF394, MAX, FOXG1, ZNF20, RPAP1, RLF, SUPT6H, GTF2E2, ZNF549, HLTF, HIVEP1, ZNF548, HESX1, NLRP3, SUDS3, ZNF544, TRAPPC2, TFAP2A, ZNF264, DR1, ZNF260, INTS3, PBX3, CNOT10, FLI1, SOX30, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT1, SP1, SP3, ZNF30, MAFF, BCL3, ZNF658, NFE2L3, INTS4, CNOT8, TMEM18, ZNF532, ZNF410, EZH2, PHF3, SETD5, CIITA, BTG2, ONECUT2, ELL, INTS10, ATF7IP2, HOXC13, CHD1, NIPBL, ZMYM2, LBH, SCML1, C1QBP, NUP62, ZNF768, ZNF525, LRRFIP1, ZNF485, TSC22D4, KLF12, TBP, KLF13, BUD31, COMMD3, ARNT, BAZ1A, SAFB, PPRC1, ZFX, MED29, SIRT2, CREB3, ZNF519, TFDP2, TFEC, LCOR, VGLL4, ZNF630, ITGB3BP, HDAC3, ZNF350, HDAC1, WBP2, ZNF69, ARNTL, SERTAD3, POLR2B, TP53INP2, TP53INP1, TAF1A, POLR2G, GPBP1L1, ASCC3, E2F7, ZNF189, E2F8, TBX1, POLR2J3, ZNF462, EYA2, NFYC, ATAD2, GRHL1, USF2, GTF2H4, PER2, GFI1B, POLR3C, NFIB, NFIC, POLR3E, TAF7, MNDA, ZNF696]
GO:0045599;negative regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;5.948432231191374;0.0038363580074348307;0.6273234135236593;[IL6, RORA, SIRT2, ARNTL]
GO:0048469;cell maturation;3.0;0.6954798709641801;0.5458602480722345;8.242229891372231;25.22197897315013;4.886724499458715;8.441569379239579E-4;0.4480276307483924;[CDKN1A, GNAQ, FGG, SOX8, FBXO5, CCL19, SCARF1, RUNX2]
GO:0006631;fatty acid metabolic process;7.0;0.5408746917014966;0.6213567111079488;7.849668188099975;91.0232021896581;4.037280715501235;0.0030464646617242943;0.5573860888006872;[ELOVL5, ACSL6, HSD17B4, ETFB, HSD17B8, PER2, C3, SGPL1, ALDH5A1, ACOX2, CPT2, NDUFS6, DAGLB, FADS1, ACOT4, MGLL]
GO:0006511;ubiquitin-dependent protein catabolic process;8.0;0.7369933605727446;0.7434966802863723;9.190269321560967;156.4521708431119;3.582668236575797;0.005236313360306564;0.5582178202295975;[USP36, USP32, CCNF, UBE2L3, PSMD8, TRIM9, PSMD2, CDC26, SKP2, C18orf25, USP46, FBXO18, DTX3L, RAD23A, SIRT2, DDB1, PSMA1, KCTD10, ANAPC5, MAN1B1, USP41, RNF38, USP12, DERL2, NEDD8, PSMB10, PSMA7, ANAPC11, ARNTL, RNF213, TP53INP2, UBD, PSMB1, UBQLN1, USP51, RFFL, UBE2I, LRRC29, UBE2B, KLHL25, EDEM1, SYVN1, FBXL15, ERLIN2, FBXL16, KBTBD4, NSFL1C, ITCH, FBXL3, TRIM32, MAD2L1]
GO:0045086;positive regulation of interleukin-2 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.292166977892469;0.027942676825076673;0.747921758369865;[CD4, CD80, GLMN]
GO:0032735;positive regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.311337724880743;0.002183412136085803;0.6458824173477649;[IL23A, CCL19]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[BCR, UPF1, IL6, ABCC2, PABPN1, NLRP7, TBXA2R, CCL20, GFI1, CD80, NLRP3, PDCD1LG2]
GO:0002548;monocyte chemotaxis;7.0;1.0;0.8509193652572005;9.628524252492122;125.46101547564297;6.039404009397101;0.004199067280386423;0.6597747671587765;[IL6, CCL20, CCL5, CCL19, CCR2]
GO:0042130;negative regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;581.9323154417883;5.734022359845919;0.01947675089275457;0.6894787953221185;[ITCH, TWSG1, CD80, GLMN, PDCD1LG2]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[AVEN, BTG2, CDKN1A, DOCK8, CIB1, AATF, NUP62, CASP2, SOX8, TSC22D4, FGA, DFFA, FCER1G, CSNK2A1, SPHK2, SPHK1, FGG, PLAUR, FLT3LG, YWHAZ, DDB1, CREB3, SFRP1, CFDP1, PTRH2, VDAC2, ADNP, EPHA1, BECN1, HDAC3, HDAC1, NLRC4, THBS1, BAG3, CCL5, LMNA, NCKAP1L, CCL19, RFFL, SNCB, BID, NTSR1, TBX1, TFAP2A, UBE2B, EYA2, SYVN1, SETX, VIL1, NFKBIA, ITCH, IL6, SON, COPS5, BCL3, PDCD1, TRIM32, MAD2L1, CPEB4]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CCL20, CCL5, CIB1, CCL19, CCR2]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[ANKRD17, COLEC12, HIST1H2BJ, NCF1, CFH, DEFB1, NLRC4, LILRA2, LYST, C2, C3, PPP6C, PRDX1, C1QBP, SLAMF7, NLRP3, APOL1, FGA, APOBEC3F, FCER1G, DTX3L, APOBEC3H, WRNIP1, RNASE3, TMEM173, SIRT2, ITCH, POLR3C, IL23A, FES, POLR3E, TRIM14, PTX3, SERINC3, TRIM32, CD244, C1QC, HIST1H2BC]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[USP36, WDR48, USP32, CCNF, OTUD7B, USP39, UBE2L3, YY1, SENP6, PSMD8, POLB, TRIM9, NPEPPS, PSMD2, CDC26, CASP2, SKP2, CTSE, C18orf25, USP46, FGA, PDCD6IP, FBXO18, DTX3L, RHBDF2, FGG, RAD23A, SENP2, SIRT2, DDB1, SFRP1, PSMA1, ESPL1, KCTD10, PSME2, ANAPC5, MAN1B1, USP41, BECN1, RNF38, USP12, DERL2, NEDD8, LRP8, TANK, PARL, PSMB10, PSMA7, ANAPC11, ARNTL, C2, C3, VCPIP1, RHOT1, RNF213, TP53INP2, UBD, PSMB1, ADAM23, UBQLN1, NLRP3, USP51, RFFL, SEC11A, UBE2I, LRRC29, UBE2B, KLHL25, EDEM1, SYVN1, FBXL15, LNPEP, ERLIN2, FBXL16, PGA3, PGA5, CAPN13, NFKBIA, KBTBD4, NSFL1C, ITCH, COPS5, XPNPEP1, FAP, FBXL3, TRIM32, C1QC, MAD2L1]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[HRK, DIABLO, NLRC4, THBS1, BBC3, STK3, ABR, FLCN, RPS6KA2, C1QBP, CCL5, UBD, TP53INP1, CASP2, NLRP3, SUDS3, ZNF622, ECT2, BID, RBM5, NTSR1, TFAP2A, DFFA, FBXO18, ATPIF1, PLAUR, EIF2AK3, G0S2, HSPE1, YWHAZ, SIRT2, NLRP12, SFRP1, IL6, GAL, TFDP2, FAP, PTRH2, MNDA, PDCD1, SERINC3, ARHGEF5, ITGB3BP]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[FGA, CD4, KARS, CCL20, CCL5, FGG, CIB1, CCL19, EPHA1]
GO:0071347;cellular response to interleukin-1;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.446340287394138;0.0027327542132076126;0.6016464081682054;[YY1, UPF1, SFRP1, ABCC2, NLRP7, CCL20, CCL5, FGG, RORA, CCL19, TANK]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[RAB43, RAB20, CCL20, CCL5, VPS26B, CCL19, HLA-DPA1]
